Carlos-Galmarini-MD-PhD-Pharmactives-medical-advisor-768x907
  • Bio: Founder and CEO of Topazium Smart Medicine, a biomedical and pharmaceutical artificial intelligence platform based in Madrid, Spain. He earned his medical degree from the University of Buenos Aires. He completed an internship in clinical oncology at Marie Curie Hospital, Buenos Aires, and post-doctoral fellowships in oncology at City of Hope Hospital, Los Angeles, and Centre Léon Bérard, Lyon. He also earned a PhD in oncology and was qualified to lead research teams for Claude Bernard Lyon 1 University, France. He practiced medicine at both Marie Curie Hospital and Carlos G. Durand Hospital, Buenos Aires, and held medical research positions in oncology at Rockefeller and Lyon Sud Medical Schools, France, where he was appointed as an associate professor. He later joined PharmaMar (Madrid, Spain) as Head of Cell Biology and Pharmacogenomics, where he was in charge of drug screening, molecular biology and pharmacogenomics. He has authored more than 120 publications. In recent years, he has devoted his research to the application of artificial intelligence in healthcare, molecular biology and other related-medical fields, becoming a recognized expert in this discipline.
Clayton 2
  • Bio: Clinical pharmacologist and pharmacological nutritionist. He is the former Chair of the Forum on Food & Health (UK) and a former Senior Scientific Advisor to the UK Government’s Committee on the Safety of Medicines. He is a Fellow of the Institute of Food, Brain & Behaviour (Oxford). Paul works with leading doctors and clinical scientists at centers of clinical expertise in multiple countries, designing and supervising pre-clinical and clinical trials of pharmaco-nutritional interventions.
Natalie Vladi blue 2
  • Bio: Dr. Vladi became a licensed pharmacist and Member of the Royal Pharmaceutical Society of Great Britain in 1998. After beginning her career in hospital pharmacy, Dr. Vladi went on to work for 20 years in the research-driven pharmaceutical industry for global industry leaders GlaxoSmithKline and Merck Sharp & Dohme in Germany and as a member of the Senior Leadership Team at Deutsche Telekom Healthcare Solutions. Dr. Vladi holds a Bachelor of Pharmacy from the University of Bath, a Master of Science from Kings College London and a Ph.D. from Saint Mary’s University in Canada.
    Dr. Vladi is Managing Director of Fountain House GmbH, manufacturer of the premium food supplements brand, Foondiert. Fountain House GmbH is a member of the Federal Association of the German Pharmaceutical Industry.